Viewing nowOkodorel Tablets (Clopidogrel Sulfate)
Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Os Korea Pharmaceutical Co., Ltd.

MFDS item code 201804935 · Approved 2018.12.06 · Insurance code 629701480
Improvement of atherosclerosis symptoms and acute coronary syndrome symptoms; prevention of blood clots in atrial fibrillation
This medication is used to improve symptoms caused by atherosclerosis in adult patients with ischemic stroke, myocardial infarction, or peripheral artery disease. It is also effective in improving atherosclerotic symptoms such as cardiovascular death, myocardial infarction, stroke, and refractory ischemia in patients with acute coronary syndrome, including unstable angina or non-Q-wave myocardial infarction, who have undergone drug therapy or percutaneous coronary intervention (PCI) or coronary artery bypass graft surgery (CABG). Furthermore, for adults with atrial fibrillation who have multiple vascular risk factors and for whom vitamin K antagonists are not appropriate and the risk of bleeding is low, it is effective in reducing the risk of atherothrombotic events and thromboembolism, including stroke. Thus, this medication is used to reduce various cardiovascular diseases and thrombotic risks and improve atherosclerotic symptoms.
○ Adults 1. For patients with ischemic stroke, myocardial infarction, or peripheral arterial disease, administer clopidogrel 75 mg orally once daily. 2. For patients with acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), start treatment on the day this medicine is initiated with a loading dose of 300 mg once daily, followed by an oral maintenance dose of 75 mg once daily. In this case, aspirin 75 ~ 325 mg should be administered once daily in combination with this medicine. 3. For patients with atrial fibrillation, administer 75 mg of this medicine orally once daily. In this case, aspirin 75 ~ 100 mg should be administered once daily in combination with this medicine. This medicine may be administered with or without food.
This medication prevents platelet aggregation in the blood, thus preventing blood clotting. The effectiveness of this medication may be reduced in patients with genetically impaired CYP2C19 enzyme function, so such patients may need to consider changing their treatment or using alternative medications. Additionally, taking this medication with drugs that activate the CYP2C19 enzyme may increase the concentration of the active substance, leading to a higher risk of bleeding, and therefore, concurrent use is not recommended. Patients who are allergic to this medication or its components, patients with bleeding disorders, patients with severe liver damage, breastfeeding women, patients with genetic issues such as lactose intolerance, and those allergic to soybean oil, soybeans, or peanuts should not take this medication. Patients at high risk of bleeding, those with poor liver or kidney function, patients who have recently experienced a stroke, hypertensive patients, and elderly patients should use this medication cautiously and undergo immediate examination when bleeding symptoms are suspected. In particular, patients scheduled for surgery should discontinue this medication 5 to 7 days before the operation and resume after hemostasis is achieved. This medication may cause various adverse reactions, including bleeding, reduction in blood cells, gastrointestinal disturbances, and skin rashes; therefore, consultation with a physician should be sought when abnormal symptoms occur. When taken with other bleeding risk medications, anticoagulants, selective serotonin reuptake inhibitors (SSRIs), non-steroidal anti-inflammatory drugs (NSAIDs), etc., the risk of bleeding may increase, so caution is needed. During pregnancy, the effects on the fetus are unclear, so it should only be used when treatment for severe cardiovascular disease is necessary, and care should be taken during delivery as the risk of bleeding may increase during delivery or neural blockade. Breastfeeding women should consider discontinuing breastfeeding or stopping the medication as it may be excreted in breast milk. The safety and efficacy of this medication in children have not been adequately confirmed, and elderly patients may have an increased risk of bleeding due to declining bodily functions, so caution is needed when taking it. In the case of overdose, bleeding may worsen, and since there are no specific antidotes, treatment should be pursued, such as platelet transfusion, for severe bleeding. This medication should be kept out of reach of children, and transferring it to another container should be avoided as it may affect the quality of the medication.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture, so it must be stored in a tightly sealed container. It is recommended to maintain a storage temperature between 1 to 30 degrees Celsius.
Pink, round, film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowClopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Os Korea Pharmaceutical Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Geonil Pharmaceutical Co., Ltd.
Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Sama Pharmaceutical Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Il Yang Pharmaceutical Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Korea Union Pharmaceutical Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
(Co., Ltd.) Korea Pharma

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.